⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBLG News
FibroBiologics, Inc. Common Stock
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
prnewswire.com
FBLG
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
prnewswire.com
FBLG
Form 8-K
sec.gov
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
prnewswire.com
FBLG
FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
prnewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
prnewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
globenewswire.com
FBLG